-
Posted by
Two Blokes Jun 23 -
Filed in
Stock
-
3 views
People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given high doses but with milder side effects, according to full results of a mid-stage trial presented at a medical meeting on Monday.
